Acutus Medical attracts $2.5M for cardiac arrhythmia Dx development

Acutus Medical, which is developing an electrophysiology diagnostic to map cardiac arrhythmias, has raised an additional $2.5 million in an expanded Series A round meant to raise a total of $5 million. Investors include Index Ventures and Advent Venture Partners. This, as MedCity News reports, is meant to build on $5.4 million raised in January. The company will use the money to support ongoing technology development. Acutus is based in both San Diego, CA, and Zurich, Switzerland. Story

Suggested Articles

Sherlock Biosciences teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech in oncology, infections and the coronavirus.

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.